Clinical impact of ibrutinib with R-CHOP in untreated non-GCB DLBCL co-expressing BCL2 and MYC Genes in the phase 3 PHOENIX trial Meeting Abstract
| Authors: | Johnson, P.; Balasubramanian, S.; Hodkinson, B.; Schaffer, M.; Parisi, L.; Shreeve, S. M.; Sun, S.; Vermeulen, J.; Sehn, L. H.; Staudt, L.; Younes, A.; Wilson, W. |
| Abstract Title: | Clinical impact of ibrutinib with R-CHOP in untreated non-GCB DLBCL co-expressing BCL2 and MYC Genes in the phase 3 PHOENIX trial |
| Meeting Title: | 61st Annual Meeting and Exposition of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 134 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Dec 7-10 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2019-11-13 |
| Start Page: | 354 |
| Language: | English |
| ACCESSION: | WOS:000518218500595 |
| DOI: | 10.1182/blood-2019-124443 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 626 -- Source: Wos |
